Innovations to Showcase AsedaSciences® for its Breakthroughs in Flow Cytometry, Airing via Discovery

Share Article

DMG Productions discovers the latest breakthroughs and advances in flow cytometry.

Innovations with Ed Begley Jr. announced today that it will feature AsedaSciences® in an upcoming episode, airing third quarter 2016, via Discovery Channel. Dates and show times TBA.

AsedaSciences® was established in 2012 with the vision of becoming a leader in optimized drug discovery through innovative cellular analysis. In this segment, viewers will learn how AsedaSciences utilizes flow cytometry to produce robust, multiplexed, cell-based screens that identify the physiological effect of target compounds on human cells.

In addition, the show will explore its integration of high throughput phenotypic screens with sophisticated data reduction, which provides the global pharmaceutical industry with real time toxicity risk assessment earlier in the R&D process.

“AsedaSciences® is developing a sensitive, robust platform to assess toxicity risk in the development of new chemical entities before they become significant financial liabilities later in development. By combining reproducible human cell-based screens, bioinformatics and cloud computing into a single predictive platform, AsedaSciences can help companies identify and mitigate potential risk in the earliest stages of the drug discovery process. This provides a cost-effective tool to assist the pharmaceutical industry in their efforts to reduce late-stage compound attrition and avert potential safety issues in human clinical trials. We’re excited to participate in the Innovations series to share our progressive approach to long-standing industry practices used in toxicity risk assessment,” said Brad Calvin, President, AsedaSciences.

“AsedaSciences’ innovative, integrated approach of ‘screen, analyze, visualize,’ will allow the delivery of complex, multi-parametric, biologically rich information in a simplified form that enables rapid and informed decisions on compound progression earlier in the drug discovery process,” said Michele Nehls, Senior Producer for the series. “We look forward to enlightening the public on this groundbreaking platform.”

About AsedaSciences:
AsedaSciences provides multi-parametric, high content, high throughput phenotypic screening services to the pharmaceutical industry. The company’s unique platform utilizes the inherent strengths of flow cytometry, automated processes and sophisticated analysis of similarity to condense complex biology into multi-parametric ‘fingerprints’ for comparison between known and unknown compounds, delivering elegantly packaged analytics to enable well informed decisions earlier in the drug discovery process. For more information, visit:

About Innovations and DMG Productions:
Innovations, hosted by award winning actor Ed Begley, Jr., is an information-based series geared toward educating the public on the latest breakthroughs in all areas of society. Featuring practical solutions and important issues facing consumers and professionals alike, Innovations focuses on cutting-edge advancements in everything from health and wellness to global business, renewable energy, and more.

DMG Productions (responsible for creating the Innovations show) includes personnel specialized in various fields from agriculture to medicine, independent films to regional news and more. Field producers work closely with experts in the field to develop stories. This powerful force enables DMG to consistently produce commercial-free, educational programming that both viewers and networks depend on.

For more information visit: or contact Michele Nehls at (866) 496-4065 x 822 or via email at Michele(at)InnovationsTelevision(dot)com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michele Nehls
DMG Productions
+1 866-496-4065 Ext: 802
Email >
Visit website